Clinical pharmacokinetics of tyrosine kinase inhibitors
van Erp, Nielka P, Gelderblom, Hans, Guchelaar, Henk-Jan
Published in Cancer treatment reviews (01.12.2009)
Published in Cancer treatment reviews (01.12.2009)
Get full text
Journal Article
Impact of Concomitant Administration of Gastric Acid-Suppressive Agents and Pazopanib on Outcomes in Soft-Tissue Sarcoma Patients Treated within the EORTC 62043/62072 Trials
Mir, Olivier, Touati, Nathan, Lia, Michela, Litière, Saskia, Le Cesne, Axel, Sleijfer, Stefan, Blay, Jean-Yves, Leahy, Michael, Young, Robin, Mathijssen, Ron H J, Van Erp, Nielka P, Gelderblom, Hans, Van der Graaf, Winette T, Gronchi, Alessandro
Published in Clinical cancer research (01.03.2019)
Published in Clinical cancer research (01.03.2019)
Get full text
Journal Article
Imatinib, sunitinib and pazopanib: From flat‐fixed dosing towards a pharmacokinetically guided personalized dose
Westerdijk, Kim, Desar, Ingrid M.E., Steeghs, Neeltje, Graaf, Winette T.A., Erp, Nielka P.
Published in British journal of clinical pharmacology (01.02.2020)
Published in British journal of clinical pharmacology (01.02.2020)
Get full text
Journal Article
Sunitinib in Refractory Adrenocortical Carcinoma: A Phase II, Single-Arm, Open-Label Trial
Kroiss, Matthias, Quinkler, Marcus, Johanssen, Sarah, van Erp, Nielka P, Lankheet, Nienke, Pöllinger, Alexander, Laubner, Katharina, Strasburger, Christian J, Hahner, Stefanie, Müller, Hans-Helge, Allolio, Bruno, Fassnacht, Martin
Published in The journal of clinical endocrinology and metabolism (01.10.2012)
Published in The journal of clinical endocrinology and metabolism (01.10.2012)
Get full text
Journal Article
mTOR inhibitor‐induced interstitial lung disease in cancer patients: Comprehensive review and a practical management algorithm
Willemsen, Annelieke E.C.A.B., Grutters, Jan C., Gerritsen, Winald R., van Erp, Nielka P., van Herpen, Carla M.L., Tol, Jolien
Published in International journal of cancer (15.05.2016)
Published in International journal of cancer (15.05.2016)
Get full text
Journal Article
Clinical Pharmacokinetics and Pharmacodynamics of the Next Generation Androgen Receptor Inhibitor—Darolutamide
Podgoršek, Eva, Mehra, Niven, van Oort, Inge M., Somford, Diederik M., Boerrigter, Emmy, van Erp, Nielka P.
Published in Clinical pharmacokinetics (01.08.2023)
Published in Clinical pharmacokinetics (01.08.2023)
Get full text
Journal Article
Quantification of cobimetinib, cabozantinib, dabrafenib, niraparib, olaparib, vemurafenib, regorafenib and its metabolite regorafenib M2 in human plasma by UPLC–MS/MS
Krens, Stefanie D., Meulen, Eric, Jansman, Frank G.A., Burger, David M., Erp, Nielka P.
Published in Biomedical chromatography (01.03.2020)
Published in Biomedical chromatography (01.03.2020)
Get full text
Journal Article
Deep and ongoing response of castrate-resistant prostate cancer on very low-dose enzalutamide in an elderly chemotherapy–naïve patient: a case report
Boerrigter, Emmy, Havenith, Thomas, van Erp, Nielka P., Schnog, John-John B.
Published in Cancer chemotherapy and pharmacology (01.07.2021)
Published in Cancer chemotherapy and pharmacology (01.07.2021)
Get full text
Journal Article
Exposure-response analyses of cabozantinib in patients with metastatic renal cell cancer
Krens, Stefanie D, van Erp, Nielka P, Groenland, Stefanie L, Moes, Dirk Jan A R, Mulder, Sasja F, Desar, Ingrid M E, van der Hulle, Tom, Steeghs, Neeltje, van Herpen, Carla M L
Published in BMC cancer (02.03.2022)
Published in BMC cancer (02.03.2022)
Get full text
Journal Article
A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma - the DUCT study protocol
Weijers, Jetty A M, Verhaegh, Gerald W, Lassche, G, van Engen-van Grunsven, Adriana C H, Driessen, Chantal M L, van Erp, Nielka P, Jonker, Marianne A, Schalken, Jack A, van Herpen, Carla M L
Published in BMC cancer (20.09.2024)
Published in BMC cancer (20.09.2024)
Get full text
Journal Article
The impact of patient characteristics on enzalutamide pharmacokinetics and how this relates to treatment toxicity and efficacy in metastatic prostate cancer patients
Benoist, Guillemette E., van Oort, Inge M., Burger, David M., Mehra, Niven, van Erp, Nielka P.
Published in Cancer chemotherapy and pharmacology (01.04.2020)
Published in Cancer chemotherapy and pharmacology (01.04.2020)
Get full text
Journal Article
Therapeutic Drug Monitoring of Oral Anticancer Drugs: The Dutch Pharmacology Oncology Group-Therapeutic Drug Monitoring Protocol for a Prospective Study
Groenland, Stefanie L, van Eerden, Ruben A G, Verheijen, Remy B, Koolen, Stijn L W, Moes, Dirk Jan A R, Desar, Ingrid M E, Reyners, Anna K L, Gelderblom, Hans J, van Erp, Nielka P, Mathijssen, Ron H J, Huitema, Alwin D R, Steeghs, Neeltje
Published in Therapeutic drug monitoring (01.10.2019)
Published in Therapeutic drug monitoring (01.10.2019)
Get more information
Journal Article
The impact of a 1‐hour time interval between pazopanib and subsequent intake of gastric acid suppressants on pazopanib exposure
Krens, Stefanie D., Lubberman, Floor J. E., Egmond, Marthe, Jansman, Frank G. A., Burger, David M., Hamberg, Paul, Vervenne, Walter L., Gelderblom, Hans, Graaf, Winette T. A., Desar, Ingrid M. E., Herpen, Carla M. L., Erp, Nielka P.
Published in International journal of cancer (01.06.2021)
Published in International journal of cancer (01.06.2021)
Get full text
Journal Article
Prognostic Value of Novel Liquid Biomarkers in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: A Prospective Observational Study
Benoist, Guillemette E, van Oort, Inge M, Boerrigter, Emmy, Verhaegh, Gerald W, van Hooij, Onno, Groen, Levi, Smit, Frank, de Mol, Pieter, Hamberg, Paul, Dezentjé, Vincent O, Mehra, Niven, Gerritsen, Winald, Somford, Diederik M, van Erp, Nielka P H, Schalken, Jack A
Published in Clinical chemistry (Baltimore, Md.) (01.06.2020)
Published in Clinical chemistry (Baltimore, Md.) (01.06.2020)
Get full text
Journal Article
Pharmacogenetic Pathway Analysis for Determination of Sunitinib-Induced Toxicity
VAN ERP, Nielka P, EECHOUTE, Karel, GUCHELAAR, Henk-Jan, GELDERBLOM, Hans, VAN DER VELDT, Astrid A, HAANEN, John B, REYNERS, An K. L, MATHIJSSEN, Ron H. J, BOVEN, Epie, VAN DER STRAATEN, Tahar, BAAK-PABLO, Renée F, WESSELS, Judith A. M
Published in Journal of clinical oncology (10.09.2009)
Published in Journal of clinical oncology (10.09.2009)
Get full text
Journal Article
Lean Body Mass and Total Body Weight Versus Body Surface Area as a Determinant of Docetaxel Pharmacokinetics and Toxicity
Hoge, Rien H L, Detert Oude Weme, Suzan E H, Vervenne, Walter L, van Berlo-van de Laar, Inge R F, van Herpen, Carla M L, Roorda, Laurens, Mathôt, Ron A A, Jacobs, Maartje S, van Erp, Nielka P, Jansman, Frank G A
Published in Therapeutic drug monitoring (01.12.2022)
Published in Therapeutic drug monitoring (01.12.2022)
Get more information
Journal Article
Dried blood spot analysis for therapeutic drug monitoring of pazopanib
de Wit, Djoeke, den Hartigh, Jan, Gelderblom, Hans, Qian, Yanwen, den Hollander, Margret, Verheul, Henk, Guchelaar, Henk-Jan, van Erp, Nielka P
Published in Journal of clinical pharmacology (01.12.2015)
Published in Journal of clinical pharmacology (01.12.2015)
Get more information
Journal Article